Review
doi: 10.1146/annurev.med.60.101107.134802.Cancer screening: the clash of science and intuition
Affiliations
- PMID:18803476
- DOI: 10.1146/annurev.med.60.101107.134802
Item in Clipboard
Review
Cancer screening: the clash of science and intuition
Barnett S Kramer et al. Annu Rev Med.2009.
Display options
Format
Display options
Format
Abstract
The concept of early detection of cancer holds great promise and intuitive appeal. However, powerful biases can mislead clinicians when evaluating the efficacy of screening tests by clinical observation alone. Selection bias, lead-time bias, length-biased sampling, and overdiagnosis are counterintuitive concepts with critical implications for early-detection efforts. This article explains these biases and other common confounders in cancer screening. The most direct and reliable way to avoid being led astray by intuitions is through the use of randomized controlled trials.
Similar articles
- The science of early detection.Kramer BS.Kramer BS.Urol Oncol. 2004 Jul-Aug;22(4):344-7. doi: 10.1016/j.urolonc.2003.04.001.Urol Oncol. 2004.PMID:15283894Review.
- Screening for cancer: evaluating the evidence.Gates TJ.Gates TJ.Am Fam Physician. 2001 Feb 1;63(3):513-22.Am Fam Physician. 2001.PMID:11272300Review.
- [Problems in using survival data of cancer patients as a method of gauging the effectiveness of cancer control efforts].Oshima A.Oshima A.Gan No Rinsho. 1988 Oct;34(12):1637-41.Gan No Rinsho. 1988.PMID:3193607Japanese.
- Bias in breast cancer research in the screening era.Cox B, Sneyd MJ.Cox B, et al.Breast. 2013 Dec;22(6):1041-5. doi: 10.1016/j.breast.2013.07.046. Epub 2013 Aug 26.Breast. 2013.PMID:23988397Review.
- Cancer screenings, diagnostic technology evolution, and cancer control.Stracci F.Stracci F.Methods Mol Biol. 2009;471:107-36. doi: 10.1007/978-1-59745-416-2_6.Methods Mol Biol. 2009.PMID:19109777
Cited by
- Personalized medicine in cardiovascular diseases.Lee MS, Flammer AJ, Lerman LO, Lerman A.Lee MS, et al.Korean Circ J. 2012 Sep;42(9):583-91. doi: 10.4070/kcj.2012.42.9.583. Epub 2012 Sep 27.Korean Circ J. 2012.PMID:23091501Free PMC article.
- Benefits and harms of screening for hepatocellular carcinoma in high-risk populations: systematic review and meta-analysis.Yang J, Yang Z, Zeng X, Yu S, Gao L, Jiang Y, Sun F.Yang J, et al.J Natl Cancer Cent. 2023 Feb 24;3(3):175-185. doi: 10.1016/j.jncc.2023.02.001. eCollection 2023 Sep.J Natl Cancer Cent. 2023.PMID:39035193Free PMC article.
- Prodromal Parkinson's disease: hype or hope for disease-modification trials?Mahlknecht P, Marini K, Werkmann M, Poewe W, Seppi K.Mahlknecht P, et al.Transl Neurodegener. 2022 Feb 21;11(1):11. doi: 10.1186/s40035-022-00286-1.Transl Neurodegener. 2022.PMID:35184752Free PMC article.Review.
- Dépistage : quand les choses tournent mal.Dickinson JA, Pimlott N, Grad R, Singh H, Szafran O, Wilson BJ, Groulx S, Thériault G, Bell NR.Dickinson JA, et al.Can Fam Physician. 2018 Jul;64(7):e299-e306.Can Fam Physician. 2018.PMID:30002039Free PMC article.French.No abstract available.
- Complex-I Alteration and Enhanced Mitochondrial Fusion Are Associated With Prostate Cancer Progression.Philley JV, Kannan A, Qin W, Sauter ER, Ikebe M, Hertweck KL, Troyer DA, Semmes OJ, Dasgupta S.Philley JV, et al.J Cell Physiol. 2016 Jun;231(6):1364-74. doi: 10.1002/jcp.25240. Epub 2015 Nov 24.J Cell Physiol. 2016.PMID:26530043Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources